BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15979629)

  • 1. Role of the macrophage very-low-density lipoprotein receptor in atherosclerotic lesion development.
    Eck MV; Oost J; Goudriaan JR; Hoekstra M; Hildebrand RB; Bos IS; van Dijk KW; Van Berkel TJ
    Atherosclerosis; 2005 Dec; 183(2):230-7. PubMed ID: 15979629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Egr-1 deficiency in bone marrow-derived cells reduces atherosclerotic lesion formation in a hyperlipidaemic mouse model.
    Albrecht C; Preusch MR; Hofmann G; Morris-Rosenfeld S; Blessing E; Rosenfeld ME; Katus HA; Bea F
    Cardiovasc Res; 2010 May; 86(2):321-9. PubMed ID: 20110335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggressive very low-density lipoprotein (VLDL) and LDL lowering by gene transfer of the VLDL receptor combined with a low-fat diet regimen induces regression and reduces macrophage content in advanced atherosclerotic lesions in LDL receptor-deficient mice.
    MacDougall ED; Kramer F; Polinsky P; Barnhart S; Askari B; Johansson F; Varon R; Rosenfeld ME; Oka K; Chan L; Schwartz SM; Bornfeldt KE
    Am J Pathol; 2006 Jun; 168(6):2064-73. PubMed ID: 16723719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low density lipoprotein receptor of macrophages facilitates atherosclerotic lesion formation in C57Bl/6 mice.
    Herijgers N; Van Eck M; Groot PH; Hoogerbrugge PM; Van Berkel TJ
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1961-7. PubMed ID: 10938018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage phospholipid transfer protein contributes significantly to total plasma phospholipid transfer activity and its deficiency leads to diminished atherosclerotic lesion development.
    Vikstedt R; Ye D; Metso J; Hildebrand RB; Van Berkel TJ; Ehnholm C; Jauhiainen M; Van Eck M
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):578-86. PubMed ID: 17170377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse very low-density lipoprotein receptor (VLDLR): gene structure, tissue-specific expression and dietary and developmental regulation.
    Tiebel O; Oka K; Robinson K; Sullivan M; Martinez J; Nakamuta M; Ishimura-Oka K; Chan L
    Atherosclerosis; 1999 Aug; 145(2):239-51. PubMed ID: 10488949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow-derived multidrug resistance protein ABCB4 protects against atherosclerotic lesion development in LDL receptor knockout mice.
    Pennings M; Hildebrand RB; Ye D; Kunne C; Van Berkel TJ; Groen AK; Van Eck M
    Cardiovasc Res; 2007 Oct; 76(1):175-83. PubMed ID: 17560559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Important role for bone marrow-derived cholesteryl ester transfer protein in lipoprotein cholesterol redistribution and atherosclerotic lesion development in LDL receptor knockout mice.
    Van Eck M; Ye D; Hildebrand RB; Kar Kruijt J; de Haan W; Hoekstra M; Rensen PC; Ehnholm C; Jauhiainen M; Van Berkel TJ
    Circ Res; 2007 Mar; 100(5):678-85. PubMed ID: 17293475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice.
    Potteaux S; Combadière C; Esposito B; Lecureuil C; Ait-Oufella H; Merval R; Ardouin P; Tedgui A; Mallat Z
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1858-63. PubMed ID: 16763157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice.
    Babaev VR; Yancey PG; Ryzhov SV; Kon V; Breyer MD; Magnuson MA; Fazio S; Linton MF
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1647-53. PubMed ID: 15947238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
    Atkinson RD; Coenen KR; Plummer MR; Gruen ML; Hasty AH
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E284-90. PubMed ID: 18029445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: marked induction of scavenger receptor and VLDL receptor expression during lesion development.
    Hiltunen TP; Luoma JS; Nikkari T; Ylä-Herttuala S
    Circulation; 1998 Mar; 97(11):1079-86. PubMed ID: 9531255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-degrading enzyme deficiency in bone marrow cells increases atherosclerosis in LDL receptor-deficient mice.
    Caravaggio JW; Hasu M; MacLaren R; Thabet M; Raizman JE; Veinot JP; Marcel YL; Milne RW; Whitman SC
    Cardiovasc Pathol; 2013; 22(6):458-64. PubMed ID: 23684818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin receptor antagonism uncouples lipids from atherosclerosis susceptibility.
    van der Sluis RJ; van den Aardweg T; Reuwer AQ; Twickler MT; Boutillon F; Van Eck M; Goffin V; Hoekstra M
    J Endocrinol; 2014 Sep; 222(3):341-50. PubMed ID: 25063756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P55 tumour necrosis factor receptor in bone marrow-derived cells promotes atherosclerosis development in low-density lipoprotein receptor knock-out mice.
    Xanthoulea S; Gijbels MJ; van der Made I; Mujcic H; Thelen M; Vergouwe MN; Ambagts MH; Hofker MH; de Winther MP
    Cardiovasc Res; 2008 Nov; 80(2):309-18. PubMed ID: 18628255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VLDL receptor deficiency enhances intimal thickening after vascular injury but does not affect atherosclerotic lesion area.
    Tacken PJ; Delsing DJ; Gijbels MJ; Quax PH; Havekes LM; Hofker MH; van Dijk KW
    Atherosclerosis; 2002 May; 162(1):103-10. PubMed ID: 11947903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage-specific expression of mannose-binding lectin controls atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Matthijsen RA; de Winther MP; Kuipers D; van der Made I; Weber C; Herias MV; Gijbels MJ; Buurman WA
    Circulation; 2009 Apr; 119(16):2188-95. PubMed ID: 19380618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical role of macrophages in glucocorticoid driven vascular calcification in a mouse-model of atherosclerosis.
    Preusch MR; Rattazzi M; Albrecht C; Merle U; Tuckermann J; Schütz G; Blessing E; Zoppellaro G; Pauletto P; Krempien R; Rosenfeld ME; Katus HA; Bea F
    Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2158-64. PubMed ID: 18787189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of glutathione reductase in macrophages decreases atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice.
    Qiao M; Kisgati M; Cholewa JM; Zhu W; Smart EJ; Sulistio MS; Asmis R
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1375-82. PubMed ID: 17363688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of human OSBP-related protein 1L in macrophages enhances atherosclerotic lesion development in LDL receptor-deficient mice.
    Yan D; Jauhiainen M; Hildebrand RB; Willems van Dijk K; Van Berkel TJ; Ehnholm C; Van Eck M; Olkkonen VM
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1618-24. PubMed ID: 17478758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.